Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Celldex Therapeutics Inc (CLDX)  
$41.65 0.91 (2.14%) as of 4:30 Mon 5/6


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 62,894,000
Market Cap: 2.62(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $22.61 - $51.88
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Diagnostic Substances

Member Indexes:
    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Celldex Therapeutics is a biopharmaceutical company focused on developing therapeutic monoclonal and bispecific antibodies. Co.'s clinical development programs include: CDX-0159, which is a human monoclonal antibody that specifically binds the receptor tyrosine kinase KIT; CDX-1140, which is a human monoclonal antibody targeted to CD40, a key activator of immune response, which is being studied in a Phase1 study; and CDX-527, which is a bispecific antibody that uses Co.'s proprietary anti-PD-L1 and CD27 human antibodies to couple CD27 co-stimulation with blockade of the PD-L1/PD-1 pathway, for which Co. has initiated a Phase 1 study in advanced solid tumors.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 223,855
Total Sell Value $0 $0 $0 $8,358,941
Total People Sold 0 0 0 6
Total Sell Transactions 0 0 0 8
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 240
  Page 10 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Furlong Michael E Sr. Dir. Bus. Development   •       –      –    2004-07-01 4 A $2.26 $1,131 D/D 500 1,000     -
   Catlin Avery W Sr. VP & CFO   •       –      –    2004-07-01 4 A $2.26 $1,131 D/D 500 6,500     -
   Kyle Frederick W Director   –       •      –    2004-05-13 4 S $2.72 $27,299 D/D (10,000) 7,000     -
   Kyle Frederick W Director   –       •      –    2004-05-13 4 OE $1.71 $17,050 D/D 10,000 9,600     -
   Kyle Frederick W Director   –       •      –    2004-04-27 4 S $2.89 $60,979 D/D (21,100) 7,000     -
   Kyle Frederick W Director   –       •      –    2004-04-27 4 OE $1.23 $29,562 D/D 21,100 17,000     -
   Ward J Barrie Director   –       •      –    2004-03-11 4 OE $0.64 $212,570 D/D 332,141 367,915     -
   Ward J Barrie Director   –       •      –    2004-03-11 4/A OE $0.64 $212,570 D/D 332,141 367,915     -
   Ward J Barrie Director   –       •      –    2004-02-27 4 S $2.69 $187,950 D/D (70,000) 35,774     -
   Furlong Michael E Sr. Dir. Bus. Development   •       –      –    2004-01-07 4 A $2.31 $1,156 D/D 500 500     -
   Helstosky Anthony Sr.Dir Reg Affairs   –       –      –    2004-01-06 4 OE $1.14 $3,420 D/D 3,000 6,000     -
   Ryan Una S officerTitle   •       •      –    2003-09-18 4 A $0.00 $0 D/D 400,000 456,913     -
   Ryan Una S officerTitle   •       •      –    2003-07-24 4 A $0.97 $485 D/D 500 56,913     -
   Catlin Avery W officerTitle   •       –      –    2003-07-24 4 A $0.97 $485 D/D 500 6,000     -
   Helstosky Anthony Sr.Dir Reg Affairs   –       –      –    2003-07-23 5 A $0.97 $485 D/D 500 3,000     -
  240 Records found
  Previous  10    
  Page 10 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us